Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. - Wikidata - awgldk - TriplyDB

Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

http://www.wikidata.org/entity/Q46820470

about

Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era Imaging Atherosclerosis.Coronary revascularization in the elderly with stable angina Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal Conduits for coronary bypass: strategies Impact of incomplete surgical revascularization on survival Management standards for stable coronary artery disease in India.[National disease management guidelines (NVL) for chronic CAD : What is new, what is particularly important?].ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study Conservative strategy for treatment of stable coronary artery disease.Long-term mortality of coronary artery bypass grafting and bare-metal stenting.An Overview on Coronary Heart Disease (A Comparative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic Strategies Quality of Life in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty (PTCA).Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology.Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction.Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents Coronary revascularization: 2011.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials.Cardiac surgery versus stenting: what is better for the patient?Appropriateness of percutaneous coronary intervention: a review.Revascularization strategies for patients with stable coronary artery disease.Advances in non-invasive drug delivery for atherosclerotic heart disease.Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.Relative survival and excess mortality following primary percutaneous coronary intervention for ST-elevation myocardial infarction.Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy.Impact of revascularization for patients who survive life-threatening ventricular arrhythmias.Harmonizing the Paradigm With the Data in Stable Coronary Artery Disease: A Review and Viewpoint.Utility and quality-adjusted life-years in coronary artery disease: Five-year follow-up of the MASS II trial.Mortality and morbidity of patients on the waiting list for coronary artery bypass graft surgery.Effectiveness of revascularization interventions compared with medical therapy in patients with ischemic cardiomyopathy: A systematic review protocol.ORBITA Trial: Redefining the Role of Intervention in the Treatment of Stable Coronary Disease?Revascularization for Left Main and Multivessel Coronary Artery Disease: Current Status and Future Prospects after the EXCEL and NOBLE Trials.A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment.

P2860

Q26745091-1F88EBB9-0374-445B-ADFE-4377172A9DC1 Q26764836-E3366DAD-0963-4081-ABED-69EF8D2C3EFA Q26778104-1DBB05B9-B9B5-4D9A-A75F-1B19CF1F8568 Q26797479-0944357E-4D3A-4070-979F-C1B339B4BCA9 Q26864819-22AD26A3-ADFF-4423-8EF7-B081996529BA Q27023988-DFDB6069-9E72-4BB6-A58F-53DEAB93AE5E Q30239853-81FCEDDB-3EF2-4747-AA43-5F958A7F9D33 Q30313892-22F58473-6181-4435-82B2-994CD7AA5A9F Q33647497-8C3B7A9A-975E-468F-BA5E-E76D892EFD24 Q33983793-1AD7B5F7-A501-41AA-9F4E-2AE975191B94 Q34463017-C4E82534-844F-47FC-A1B6-D52AAAB0758A Q35734651-F66FFAB4-F11E-4DD1-8C94-A78FA2C26CCF Q36664605-9D06DA0E-32D9-4AE1-BB90-EF719FDB0BFF Q36718199-4B81848E-69CB-488D-8145-A0F5F3CB360C Q36787252-61A770FA-A714-4B01-98BD-6865D8C791E6 Q37127474-B36E3038-3067-4465-BA3A-4A89E4C2BBF2 Q37130698-24BC9515-DBEB-4888-B248-760E057FE151 Q37862930-D1257DDF-416D-4018-86AE-582AFF4429EA Q37953885-C83B22CF-5DFF-47CC-95FB-06DBBAA4C009 Q38013670-BF43C240-4FA0-468D-BB21-9EEAAC32EEF2 Q38044498-B4FA9CD2-1A1E-4064-BA6D-FBBC422DBBBB Q38116427-96875B54-861A-4A40-A02A-452E037DF89A Q38201161-26020AB5-4BA2-47A0-8824-DA60A2A2F601 Q38317205-F1EFBD63-ADC9-40B3-8144-99D87179ECB2 Q38589870-044B60F0-19B9-4F26-95E3-1FA00078842E Q38652030-02EE72FF-3363-4EAA-BE60-A27A0A1AF6DF Q38686884-586932F5-11FF-4B98-AFEC-60E22658A2AE Q40385431-C0CF3215-BCA1-4939-B956-5A459B6C8EC4 Q40629689-28A58059-C465-4868-AF4E-E72283905EEF Q42361724-12E770C8-B648-4030-84FC-8E94B1F5568C Q43123140-3FDA7846-76EE-4DBA-B578-513DEF48A63F Q47151397-E892A336-FC65-4F8C-B1C5-4E3055EFF353 Q47553457-89FEDE53-0BAD-4CAD-A346-F58DC8E674EF Q50096799-124248D7-5D64-48DB-8637-69A0C91A7CED Q52666977-9BE363C8-C306-4EC4-B6A1-FBE971BC17B5 Q55195440-570D7970-2EC7-4018-B27D-31D0809046F8 Q55345612-8C3CBDE3-7220-42AF-8999-0A28E9F69E32 Q55690560-B84A4744-8BBB-4645-8BCB-8E52A1857C66

P2860

Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

http://www.wikidata.org/entity/Q46820470

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Ten-year follow-up survival of ...... essel coronary artery disease.

@en

Ten-year follow-up survival of ...... essel coronary artery disease.

@nl

type

label

Ten-year follow-up survival of ...... essel coronary artery disease.

@en

Ten-year follow-up survival of ...... essel coronary artery disease.

@nl

prefLabel

Ten-year follow-up survival of ...... essel coronary artery disease.

@en

Ten-year follow-up survival of ...... essel coronary artery disease.

@nl

P1433

Q46820470-2D05C78C-A57F-4E75-9A25-BC33079FFDBA

P1476

Q46820470-EBB9E804-AEB2-4734-8853-88366C05F9EE

P2093

Q46820470-0D5E7ABC-116D-470A-80C6-89FEA7550640

Q46820470-184E4A64-3041-4B37-B31B-DD52B3B12DEE

Q46820470-63D33FD9-2B2B-4E8E-BDF7-FD22B80F53D4

Q46820470-87174746-B5B9-4800-9B79-B4B9EDE1C518

Q46820470-90094B75-D130-4F6D-9BD5-08E7724FABD8

Q46820470-99538D33-2116-49EF-882C-BBAC4DACCBF2

Q46820470-AB25C726-C8D8-4390-8797-2FB7EA834548

Q46820470-C37A8DEA-5F31-4548-A88C-8F28C31FE190

Q46820470-C7F56104-B5D6-482E-8A5F-991868051E1D

Q46820470-D94B7A6D-C69D-464D-8878-88A88205C8DE

P304

Q46820470-BDC08C87-76FF-45B6-A126-8C6EC13BE35B

P31

Q46820470-E81A783D-449F-45DA-A691-E490105E666F

P356

Q46820470-16B982F6-8E78-4516-A4E1-A926070FA30E

P407

Q46820470-F518593A-3666-4F7F-8E8C-670ADA0B76AD

P433

Q46820470-B04CCB61-EA57-46B1-9FF3-34B04CB0018D

P478

Q46820470-5C823C3E-1D68-4235-A663-E875A93E7663

P577

Q46820470-5EDB22DA-B26F-4E93-A537-276B95813E1B

P698

Q46820470-3D9291FE-66D1-4B62-AF17-325B5C593B27

P356

CIRCULATIONAHA.109.911669

P1433

P1476

Ten-year follow-up survival of ...... essel coronary artery disease.

@en

P2093

Alexandre C Hueb

http://www.w3.org/2001/XMLSchema#string

Alexandre C Pereira

http://www.w3.org/2001/XMLSchema#string

Antonio Sérgio C Rocha

http://www.w3.org/2001/XMLSchema#string

Bernard J Gersh

http://www.w3.org/2001/XMLSchema#string

Desiderio Favarato

http://www.w3.org/2001/XMLSchema#string

Expedito E Ribeiro

http://www.w3.org/2001/XMLSchema#string

Jose A F Ramires

http://www.w3.org/2001/XMLSchema#string

Neuza Lopes

http://www.w3.org/2001/XMLSchema#string

Paulo R Soares

http://www.w3.org/2001/XMLSchema#string

Whady Hueb

http://www.w3.org/2001/XMLSchema#string

P304

949-957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.109.911669

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20733102

http://www.w3.org/2001/XMLSchema#string